3
Participants
Start Date
July 18, 2024
Primary Completion Date
August 30, 2024
Study Completion Date
January 30, 2025
Metformin
Metformin is a drug used to manage blood glucose levels. It improves insulin sensitivity and reduces glucose production in the liver. This regimen will be provided to all study groups (A, B, and C) in combination with the respective interventions described for each group. Participants are instructed not to change their physical activity during the study.
Cairo University, Cairo
National Police Hospital
OTHER_GOV
Cairo University
OTHER